Beyond Surgery: Does Adjuvant Therapy Still Add Value for Patients With Pancreatic Cancer After Neoadjuvant Treatment?

Labori KJ, Verbeke C

Open source

DOI
10.1245/s10434-026-20630-3
Published
2026 Sep 26
Container
Annals of surgical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1245/s10434-026-20630-3,
  title = {Beyond Surgery: Does Adjuvant Therapy Still Add Value for Patients With Pancreatic Cancer After Neoadjuvant Treatment?},
  author = {Labori KJ and Verbeke C},
  year = {2026},
  journal = {Annals of surgical oncology},
  doi = {10.1245/s10434-026-20630-3},
  url = {https://doi.org/10.1245/s10434-026-20630-3}
}

RIS

TY  - JOUR
TI  - Beyond Surgery: Does Adjuvant Therapy Still Add Value for Patients With Pancreatic Cancer After Neoadjuvant Treatment?
AU  - Labori KJ
AU  - Verbeke C
PY  - 2026
JO  - Annals of surgical oncology
DO  - 10.1245/s10434-026-20630-3
UR  - https://doi.org/10.1245/s10434-026-20630-3
ER  - 

APA

KJ, L., & C, V. (2026). Beyond Surgery: Does Adjuvant Therapy Still Add Value for Patients With Pancreatic Cancer After Neoadjuvant Treatment?. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-20630-3

Source records